Ledger.Open graph →
SEC Form D · filed September 10, 2021

Aadi Bioscience, Inc

Offering
$155.0M
Sold
$155.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Pacific Palisades, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Lance Thibault · Pacific Palisades, CAExecKarin Heneberger · Pacific Palisades, CADirectorNeil Desai · Pacific Palisades, CAExec · DirectorEmma Reeve · Pacific Palisades, CADirectorRichard Maroun · Pacific Palisades, CADirectorCaley Castelein · Pacific Palisades, CADirectorAnupam Dalal · Pacific Palisades, CADirectorEric D. Mallon · Louisville, CODirectorRay Simpson · Philadelphia, PADirectorDonatien-Xavier Martin · Grand Duchy of Luxembourg, LuxembourgExecNoel Carr · Philadelphia, PAExec · DirectorAdam C. Heflin · Phoenix, AZDirectorSteven Denbaars · Manchester, United KingdomDirectorGonzalo A. De La Melena · Phoenix, AZDirectorPatricia Costello · San Mateo, CADirectorGreg Bond · Maitland, FLExec · DirectorJenna Poole · Maitland, FLDirectorAnne Dean · CHICAGO, ILDirectorJohn Hamer · Durham, NCDirectorRay Croghan · Phoenix, AZDirectorMitchell E. Goodman · IRVINE, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗